In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

Lilja Thoenes; Miriam Hoehn; Roman Kashirin; Manfred Ogris; Georg J. Arnold; Ernst Wagner; Michael Guenther

doi:10.1016/j.jprot.2010.02.019

In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

Lilja Thoenes
, Miriam Hoehn
, Roman Kashirin
, Manfred Ogris
, Georg J. Arnold
, Ernst Wagner
, Michael Guenther

Veröffentlichungen: Beitrag in Fachzeitschrift › Artikel › Peer Reviewed

Originalsprache	Englisch
Seiten (von - bis)	1342-1354
Seitenumfang	13
Fachzeitschrift	Journal of Proteomics
Jahrgang	73
Ausgabenummer	7
DOIs	https://doi.org/10.1016/j.jprot.2010.02.019
Publikationsstatus	Veröffentlicht - 7 Mai 2010
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

ÖFOS 2012

301207 Pharmazeutische Chemie

Zugriff auf Dokument

10.1016/j.jprot.2010.02.019

Zitationsweisen

@article{c380b89715bb46fca81d46dcb2871d48,

title = "In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy",

keywords = "Antiangiogenesis, Metronomic, Low dose chemotherapy, Prostate cancer, Proteomics, Annexin A3, In vivo chemoresistance, HUMAN CATHEPSIN-B, TUMOR ANGIOGENESIS, HEPATOCELLULAR-CARCINOMA, MULTIDRUG-RESISTANCE, VASCULOGENIC MIMICRY, SIDE POPULATION, PHASE-II, CELLS, THIOREDOXIN, EXPRESSION",

author = "Lilja Thoenes and Miriam Hoehn and Roman Kashirin and Manfred Ogris and Arnold, \{Georg J.\} and Ernst Wagner and Michael Guenther",

year = "2010",

month = may,

day = "7",

doi = "10.1016/j.jprot.2010.02.019",

language = "English",

volume = "73",

pages = "1342--1354",

journal = "Journal of Proteomics",

issn = "1874-3919",

publisher = "ELSEVIER SCIENCE BV",

number = "7",

}

TY - JOUR

T1 - In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

AU - Thoenes, Lilja

AU - Hoehn, Miriam

AU - Kashirin, Roman

AU - Ogris, Manfred

AU - Arnold, Georg J.

AU - Wagner, Ernst

AU - Guenther, Michael

PY - 2010/5/7

Y1 - 2010/5/7

KW - Antiangiogenesis

KW - Metronomic

KW - Low dose chemotherapy

KW - Prostate cancer

KW - Proteomics

KW - Annexin A3

KW - In vivo chemoresistance

KW - HUMAN CATHEPSIN-B

KW - TUMOR ANGIOGENESIS

KW - HEPATOCELLULAR-CARCINOMA

KW - MULTIDRUG-RESISTANCE

KW - VASCULOGENIC MIMICRY

KW - SIDE POPULATION

KW - PHASE-II

KW - CELLS

KW - THIOREDOXIN

KW - EXPRESSION

U2 - 10.1016/j.jprot.2010.02.019

DO - 10.1016/j.jprot.2010.02.019

M3 - Article

SN - 1874-3919

VL - 73

SP - 1342

EP - 1354

JO - Journal of Proteomics

JF - Journal of Proteomics

IS - 7

ER -

In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

UN SDGs

ÖFOS 2012

Zugriff auf Dokument

Fingerprint

Zitationsweisen